| |   Follow us!
The company was founded in 2015 as a spin-off of the University of Antwerp with one goal: to develop a disruptive solution for (pancreatic) cancer and other life-threatening diseases. ElmediX’ management team of seasoned entrepreneurs and scientists is bringing this mission to life.

Contact

Zeutestraat 2B
2800 Mechelen, Belgium

Esperantolaan 4
3001 Leuven, Belgium

530 7th Ave Suite 902
New York, NY 10018, USA

Newsletter

Stay up to date with the developments of ElmediX. Sign up for our newsletter! If you have additional questions, please contact us.